SCHEMBL1616249

SCHEMBL1616249

c1ccc(-c2cccc3nc(NC4CCc5ccccc54)ccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.50
PFKFB3 Q16875 6/20 0.44
FADS1 O60427 1/20 0.42
PDPK1 O15530 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KCNN3 Q9UGI6 1/20 0.41
NSD2 O96028 2/20 0.39
EGFR P00533 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39
CDC25B P30305 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616241 1.00 GBA1 (0.50) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1615908 0.90 GBA1 (0.62) GBA1PFKFB3NSD2KDM4EMEN1
SCHEMBL1615905 0.90 GBA1 (0.62) GBA1PFKFB3NSD2KDM4EMEN1
SCHEMBL1616160 0.87 PFKFB3 (0.46) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1616397 0.87 PFKFB3 (0.46) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1616394 0.87 PFKFB3 (0.46) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL2245619 0.86 GBA1 (0.47) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1616344 0.84 GBA1 (0.46) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1615946 0.84 GBA1 (0.48) GBA1PFKFB3FADS1PDPK1HDAC6
SCHEMBL1616343 0.84 GBA1 (0.46) GBA1PFKFB3FADS1PDPK1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US claimed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP claimed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US claimed
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US disclosed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146567-A1 QUINOLINES HTR5A, HTR2B, HTR2C GBA1 662/4885PFKFB3 4177/4885FADS1 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.